CMPS Stock Summary and Trading Ideas (Compass Pathways PLC - American Depository Shares | NASDAQ:CMPS)

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Compass Pathways PLC - American Depository Shares trades on the NASDAQ stock market under the symbol CMPS.

As of August 27, 2026, CMPS stock price climbed to $14.64 with 1,577,096 million shares trading.

CMPS has a beta of 2.35, meaning it tends to be more sensitive to market movements. CMPS has a correlation of 0.13 to the broad based SPY ETF.

CMPS has a market cap of $1.98 billion. This is considered a Small Cap stock.

In the last 3 years, CMPS traded as high as $15.40 and as low as $2.25.

The top ETF exchange traded funds that CMPS belongs to (by Net Assets): ARKG, IBB, PSIL, SBIO, GWX.

CMPS has outperformed the market in the last year with a price return of +207.6% while the SPY ETF gained +20.7%. CMPS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.8% and +3.0%, respectively, while the SPY returned +3.0% and -0.2%, respectively.

CMPS support price is $14.09 and resistance is $15.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMPS shares will trade within this expected range on the day.